EUVIMEDEUVIMED entdecken
CrossrefInfokarte

Evaluation of Growth Differentiation Factor-5 Levels in Umbilical Cord Blood and Its Association with Neonatal Outcomes and Maternal Diseases

Adnan Azizoğlu, Özhan Orhan, Ferhat Kalkan, Sabahattin Ertuğrul

The European Research Journal · 2026-12-01 · 1424-1430

DOI: 10.18621/eurj.1294 ↗
AbstractBibliografische Angaben

Abstract

Objective: To evaluate the association of umbilical cord blood growth differentiation factor-5 (GDF-5) levels with neonatal clinical outcomes and maternal diseases, given its pivotal role in neurodevelopment, tissue differentiation, and repair processes. Methods: This prospective, single-center study enrolled 180 neonates born between 2015 and 2016. Serum GDF-5 concentrations were determined using a commercially available quantitative sandwich enzyme-linked immunosorbent assay (ELISA) kit (SunRed Biotechnology Company) according to the manufacturer's instructions. Neonatal demographic characteristics and maternal complications were analyzed in relation to GDF-5 levels. Results: The neonatal cohort comprised 58.9% (n = 106) males and 41.1% (n = 74) females. GDF-5 levels exhibited no significant differences when evaluated across newborn sex, mode of delivery, birth weight, gestational age, or postnatal pathologies (P > .05). However, neonates born to mothers complicated by placenta previa demonstrated significantly lower GDF-5 concentrations compared to those without placenta previa (P = .02). Conclusions: While umbilical cord blood GDF-5 levels are not correlated with the majority of neonatal outcomes, their significant reduction in cases of placenta previa suggests that GDF-5 may play a role in placental pathology-related processes.

Wissen, das zu Ihrer Arbeit passt.

Vom kostenlosen Einstieg über die persönliche Recherche bis zur vollständigen Research Suite.

Tarife ansehen →

Sind alle Verlagsvolltexte enthalten?

Nein. Bibliografische Nachweise, Abstracts und Volltexte sind unterschiedliche Inhalte. Ob ein Volltext verfügbar ist, hängt von der Quelle, Open Access und Ihren vorhandenen Lizenzen ab. Ein EUVIMED-Tarif ersetzt keine zusätzlichen Verlagsrechte.

Tarife ansehen →